Additionally, upregulation of CD47 and/or SIRPα expression on induced pluripotent stem cell-derived β-cells or islet transplants might augment their survival following β-cell replacement therapy in persons with longstanding T1D (Figure 4). Here, SIRPA is linked to type 1 diabetes mellitus.